Nephropathy In Type 2 Diabetes and Cardio-renal Events
Nephropathy in Type 2 Diabetes: Effects of an Intensive Multifactorial Intervention Trial on Cardio-renal Events.
Sponsor: University of Campania Luigi Vanvitelli
Listed as NCT00535925, this PHASE4 trial focuses on Diabetic Nephropathy and remains completed. Sponsored by University of Campania Luigi Vanvitelli, it has been updated 11 times since 2005, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 6 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE4
-
Jul 2020 — Sep 2020 [monthly]
Completed PHASE4
-
Jun 2020 — Jul 2020 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Jun 2018 — Jun 2020 [monthly]
Unknown Status PHASE4
-
Sep 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Sep 2017 [monthly]
Unknown Status PHASE4
First recorded
Oct 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Campania Luigi Vanvitelli
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Naples, Italy